Alacrity Biosciences, Inc. Report issue

For profit Phase 2
Founded: Laguna Hills CA United States (2005)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2007
NCT00439400
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

doxycycline (vibramycin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 2)

Keratoconjunctivitis Sicca (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1